Possible deleterious effect of tamoxifen in premenopausal women with locoregional recurrence of breast cancer
- 1 November 1996
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (12) , 2173-2176
- https://doi.org/10.1016/s0959-8049(96)00227-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Tamoxifen and menopausal status: risks and benefitsThe Lancet, 1996
- Discovering the Truth About Tamoxifen: Problems of Multiplicity in Statistical Evaluation of Biomedical DataJNCI Journal of the National Cancer Institute, 1995
- Use of tamoxifen for breast cancer: twenty-eight years later.Journal of Clinical Oncology, 1995
- What have we learned about risk factors for local recurrence after breast-conserving surgery and irradiation?Journal of Clinical Oncology, 1994
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Tamoxifen in premenopausal patients with metastatic breast cancer: a review.Journal of Clinical Oncology, 1991
- Improved methodology for analyzing local and distant recurrence.Journal of Clinical Oncology, 1990
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing RiskThe Annals of Statistics, 1988
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958